4G Clinical Secures $2.5M in Series A Funding
Summary
4G Clinical, a Boston, MA-based randomization and trial supply management company, secured $2.5M in Series A funding.The round was led by Boston-based Schooner Capital.The company will use the funds to build out its business and technology offering, to continue to recruit talent, and to promote the brand at industry conferences.Led by Dave Kelleher, CEO, and Ed Tourtellotte, CTO, 4G Clinical provides a randomization and trial supply management platform supporting global Phase 2 and 3 clinical trials.FinSMEs 29/01/2016
Funding
Amount
$2.5M
Total raised
Date
January 29, 2016
Announcement date
Investors
Schooner Capital LLC
Lead investors
Company
http://www.4gclinical.com
Funded company
Classifications
industries
No industries detected
applications
Web and Content Management
AskAI Classifications
Labels
Clinical Trial Software
Randomization Software
Supply Chain Optimization Software
Linked Companies
4G Clinical
$1M to $5M